PATRICK HANDLIN: Open Payments
NPI 1366421711 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 82 payments from 11 companies in 2025. Trend: 2023 $2,266 · 2024 $1,673 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 23 | $401 |
| ABBVIE INC. | 28 | $377 |
| Otsuka America Pharmaceutical, Inc. | 17 | $267 |
| Janssen Pharmaceuticals, Inc | 3 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Alkermes, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: INGREZZA, VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, ARISTADA, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
